Skip to main content
Download PDF
- Main
Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes
- Wagner, Sarah;
- Roberson, David;
- Boland, Joseph;
- Kreimer, Aimée R;
- Yeager, Meredith;
- Cullen, Michael;
- Mirabello, Lisa;
- Dunn, S Terence;
- Walker, Joan;
- Zuna, Rosemary;
- Porras, Carolina;
- Cortes, Bernal;
- Sampson, Joshua;
- Herrero, Rolando;
- Rodriguez, Ana Cecilia;
- Quint, Wim;
- Van Doorn, Leen-Jan;
- José, San;
- González, Paula;
- Herrero, Rolando;
- Jiménez, Silvia E;
- Porras, Carolina;
- Rodríguez, Ana Cecilia;
- Hildesheim, Allan;
- Kreimer, Aimée R;
- Lowy, Douglas R;
- Schiffman, Mark;
- Schiller, John T;
- Sherman, Mark;
- Wacholder, Sholom;
- Pinto, Ligia A;
- Kemp, Troy J;
- Sidawy, Mary K;
- Quint, Wim;
- van Doorn, Leen-Jan;
- Struijk, Linda;
- Palefsky, Joel M;
- Darragh, Teresa M;
- Stoler, Mark H;
- Hildesheim, Allan;
- Schiffman, Mark;
- Wentzensen, Nicolas
- et al.
Published Web Location
https://doi.org/10.1093/infdis/jiz324Abstract
Background
Human papillomaviruses (HPV) cause over 500 000 cervical cancers each year, most of which occur in low-resource settings. Human papillomavirus genotyping is important to study natural history and vaccine efficacy. We evaluated TypeSeq, a novel, next-generation, sequencing-based assay that detects 51 HPV genotypes, in 2 large international epidemiologic studies.Methods
TypeSeq was evaluated in 2804 cervical specimens from the Study to Understand Cervical Cancer Endpoints and Early Determinants (SUCCEED) and in 2357 specimens from the Costa Rica Vaccine Trial (CVT). Positive agreement and risks of precancer for individual genotypes were calculated for TypeSeq in comparison to Linear Array (SUCCEED). In CVT, positive agreement and vaccine efficacy were calculated for TypeSeq and SPF10-LiPA.Results
We observed high overall and positive agreement for most genotypes between TypeSeq and Linear Array in SUCCEED and SPF10-LiPA in CVT. There was no significant difference in risk of precancer between TypeSeq and Linear Array in SUCCEED or in estimates of vaccine efficacy between TypeSeq and SPF10-LiPA in CVT.Conclusions
The agreement of TypeSeq with Linear Array and SPF10-LiPA, 2 well established standards for HPV genotyping, demonstrates its high accuracy. TypeSeq provides high-throughput, affordable HPV genotyping for world-wide studies of cervical precancer risk and of HPV vaccine efficacy.Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%